Rakha, Emad A.

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Habashy, H. O., Powe, D. G., Staka, C. M., Rakha, E. A., Ball, G., Green, A. R., Aleskandarany, M., Paish, E. C., Douglas Macmillan, R., Nicholson, R. I., et al. (2010) · Breast Cancer Research and Treatment

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 236

Artificial intelligence in digital breast pathology: Techniques and applications

Ibrahim, A., Gamble, P., Jaroensri, R., Abdelsamea, M. M., Mermel, C. H., Chen, P.-H. C., & Rakha, E. A. (2020) · The Breast

AI in cancer detectionArtificial Intelligence in Healthcare and Education

Cited by 202

Determining breast cancer biomarker status and associated morphological features using deep learning

Gamble, P., Jaroensri, R., Wang, H., Tan, F., Moran, M., Brown, T., Flament-Auvigne, I., Rakha, E. A., Toss, M., Dabbs, D. J., et al. (2021) · Communications Medicine

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 154

Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

Mohammed, R. A. A., Ellis, I. O., Mahmmod, A. M., Hawkes, E. C., Green, A. R., Rakha, E. A., & Martin, S. G. (2011) · Modern Pathology

Breast Cancer Treatment StudiesLymphatic System and Diseases

Cited by 145